Related Experiment Videos
Patterns of bone marrow involvement with small cell lung cancer
Cancer
|July 1, 1984
Summary
Any bone marrow involvement in small cell lung cancer patients at diagnosis indicates a poor prognosis. The extent of this involvement or associated fibrosis does not further worsen outcomes, highlighting the significance of minimal tumor presence.
Area of Science:
- Oncology
- Hematology
Background:
- Small cell lung cancer (SCLC) is an aggressive malignancy.
- Bone marrow involvement is a common metastatic site in SCLC.
Purpose of the Study:
- To evaluate the prognostic significance of bone marrow involvement in small cell lung cancer.
- To correlate marrow involvement patterns with clinical outcomes and treatment tolerance.
Main Methods:
- Histopathological assessment of bone marrow biopsies from 25 SCLC patients at diagnosis.
- Evaluation of tumor extent, necrosis, reticulin, and megakaryocytosis.
- Comparison of marrow findings with patient survival and therapy response.
Main Results:
- Any degree of bone marrow involvement was identified as a negative prognostic indicator.
- The extent of tumor infiltration in the marrow did not significantly impact prognosis.
- Increased marrow fibrosis did not correlate with a worse clinical outcome.
Conclusions:
- Minimal bone marrow involvement in SCLC is a critical prognostic factor.
- Prognosis in SCLC is not significantly altered by the degree of marrow infiltration or fibrosis.